Marinus Pharma Email Format
Pharmaceutical ManufacturingPennsylvania, United States51-200 Employees
Marinus Pharmaceuticals, Inc. is a mid-sized pharmaceutical company based in Radnor, Pennsylvania, focused on developing therapies to treat seizure disorders. Positioned in the pharmaceutical manufacturing sector, it concentrates on advancing treatments for patients living with seizure-related conditions. A merger with Immedica in 2025 expanded the company’s footprint and capabilities. In 2022, Marinus entered into an exclusive patent license with Ovid Therapeutics for the use of ganaxolone in CDKL5 deficiency disorder.